PharVision Advisers’s Guidewire Software GWRE Stock Holding History

PharVision Advisers’s Portfolio GWRE Stock Details GWRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,040	Closed	-$209K	–	336
2025 Q4	$209K	Buy	+1,040	New	+$230K	0.11%	520

Other funds holding GWRE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

PharVision Advisers's GWRE Position: Q1 2026 in Review

PharVision Advisers sold out of Guidewire Software (GWRE) in Q1 2026, closing a stake of 1,040 shares — an estimated $209K sold.

PharVision Advisers first reported a position in GWRE in Q4 2025 and held it in 1 quarter. The position peaked at $209K in Q4 2025. 593 funds tracked by Wall St. Rank hold GWRE as of Q1 2026.

PharVision Advisers reported no remaining Guidewire Software position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,040 Guidewire Software shares in Q1 2026, an estimated $209K.
PharVision Advisers first reported a position in Guidewire Software in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Guidewire Software position peaked at $209K in Q4 2025.
593 funds tracked by Wall St. Rank held Guidewire Software as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.